echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Lipid-lowering drug introduced by Eddingpharm was approved in Hong Kong, China

    Lipid-lowering drug introduced by Eddingpharm was approved in Hong Kong, China

    • Last Update: 2022-04-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 29, Eddingpharm announced that the new drug marketing application of Eicosapentaenoic acid ethyl ester capsules (trade name Vascepa) for reducing the risk of cardiovascular events has been approved in Hong Kong, China.


    Vascepa is a single-molecule prescription drug containing the highly purified active ingredient ethyl eicosapentaenoate (IPE, a unique form of eicosapentaenoic acid)


    Vascepa was first marketed in the U.


    This time, Eddingpharm's submission of Vascepa's new drug marketing application in Hong Kong, China is based on the results of the REDUCE-IT study and the approval results of Vascepa in the United States and Canada


    The main findings of the REDUCE-IT study were published in the New England Journal of Medicine in November 2018


    It is reported that China's National Medical Products Administration (NMPA) has also accepted Vascepa's new drug marketing application in mainland China


    References:

    [1] Eddingpharm Receives New Drug Approval for VASCEPA® in Hong Kong, China to Reduce Risk of Cardiovascular Events.


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.